Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

Rang in Aktien #2100
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Aktienkurs
$141.26
Marktkapitalisierung
$9.80B
Veränderung (1 Tag)
-0.97%
Veränderung (1 Jahr)
-57.06%
Land
US
Handel Insulet Corp. (PODD)

Kategorie

Healthcare
Kursverlauf für Insulet Corp. (PODD)
Höchster Schlusskurs: $136.99 am 2026-10-01

Niedrigster Schlusskurs: $15.32 am 2007-05-01
Kursverlauf der Aktie von Insulet Corp. von 2007 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -28.62%
2025 10.94%
2024 29.28%
2023 -31.55%
2022 12.13%
2021 7.15%
2020 41.98%
2019 122.73%
2018 14.06%
2017 87.47%
2016 -0.45%
2015 -18.45%
2014 23.64%
2013 70.93%
2012 17.30%
2011 23.42%
2010 14.55%
2009 83.92%
2008 -70.52%
2007 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$98.44 -22.82%
US
$93.51 -2.42%
IE
$296.58 -21.90%
US
$44.31 -55.65%
US
$46.69 -17.17%
DE